Teevir Tablet

Teevir Tablet contains Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate is an antiretroviral medication used in the treatment of HIV-1 infection. 

Brand Name: Teevir

Composition: Efavirenz 600mg, Tenofovir Disoproxil Fumarate 300mg, Emtricitabine 200mg

Mechanism of Action:

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that prevents HIV from replicating by blocking the reverse transcriptase enzyme.

The reverse transcriptase enzyme is inhibited by tenofovir and emtricitabine, which stops viral RNA from being converted to DNA and stops the virus from multiplying inside the host cells. By lowering the blood's viral load, this dual action strengthens the immune system and lowers the risk of consequences from HIV.

Uses:

• HIV-1 Infection

Dosage and Administration:

One tablet taken once a day, with or without food, is the usual dosage.

Side Effects:

• Fatigue
• Headache
• Nausea
• Vomiting
• Fever
• Cough
• Insomnia
• Liver Function Abnormalities
• Allergic Reactions
• Abnormal/vivid dreams, dizziness, and impaired concentration
• Psychiatric symptoms, including depression, anxiety, and, rarely, suicidal ideation

Contraindications/Warnings: 

Efavirenz carries a risk of serious psychiatric symptoms (severe depression, suicidal ideation or attempts, aggressive behaviour, paranoia, psychosis) and prominent CNS effects (dizziness, impaired concentration, abnormal dreams, insomnia), which typically occur in the first weeks of therapy  patients with a psychiatric history should be monitored closely. Teevir should not be co-administered with other tenofovir- or emtricitabine-containing products. In patients coinfected with HIV and hepatitis B, severe acute exacerbations of hepatitis B have been reported upon discontinuation; hepatic function should be monitored closely for several months after stopping treatment. Efavirenz has significant CYP3A4-mediated drug interactions and can prolong the QT interval; it is contraindicated with several drugs metabolised through this pathway.

Safety Advise:

Kidney  

Monitor kidney function regularly, as Teevir can cause nephrotoxicity. Kindly speak with your healthcare provider.

Liver  

Monitor liver function regularly, as Teevir can cause liver impairment. Kindly speak with your healthcare provider.

Lungs 

The safety of Teevir for individuals with lung issues is uncertain. Kindly speak with your healthcare provider.

Pregnancy  

Teevir should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Teevir while nursing is most likely dangerous. Kindly speak with your healthcare provider.

Alcohol  

Teevir should not be taken with alcohol. Kindly speak with your healthcare provider.

Storage:

Store Teevir Tablet at a temperature between 15°C and 30°C (59°F to 86°F). Keep the tablets in the original packaging to protect them from light and moisture. Keep out of reach of children.

How to use this Medication?

Drink a glass of water along with this prescription. Take it daily at the same time as specified on the prescription label. Consume it with food. Take each dose exactly as directed on the prescription label for the best potential outcome from your therapy. Don't miss any dosages. The virus may become resistant to this and other medications if doses are skipped. Unless instructed otherwise by your care team, continue taking this therapy.

 
Discuss the usage of this drug in children with your care team. For certain illnesses, it can be administered to youngsters as young as 12, although there are safety precautions to take.

References:

1.     Pozniak AL, Gallant JE, DeJesus E, Arribas JR, Gazzard B, Campo RE, Chen SS, McColl D, Enejosa J, Toole JJ, Cheng AK. Tenofovir disoproxil fumarate,   emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes-a 96-week analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2006 Dec 15;43(5):535-40.

2.     Frampton JE, Croom KF. Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet. Drugs. 2006 Aug;66:1501-12.

3.     Dando TM, Wagstaff AJ. Emtricitabine/tenofovir disoproxil fumarate. Drugs. 2004 Sep;64:2075-82.

Disclaimer:

The main goal of Apothecare Specialities Pvt Ltd is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Specialities Pvt Ltd, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Address: Mylan Pharmaceuticals Private Limited, Commercial Operations, Prestige Tech Park, Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103
Country of origin: India